Efficacy and safety of risperidone in the treatment of children with autistic and other pervasive developmental disorders (PDD): A randomized, double-blind, placebo controlled trial

被引：1
|
作者：
Light, M
Dunbar, E
Shea, SE
机构：
[1] Janssen Ortho Inc, Clin Affairs, Toronto, ON, Canada
[2] IWK Hlth Ctr, Dev Clin, Halifax, NS, Canada
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2004年 / 14卷
关键词：
D O I：
10.1016/S0924-977X(04)80324-9
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S278 / S278
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of risperidone in the treatment of children with autistic and other pervasive developmental disorders (PDD): A randomized, double-blind, placebo-controlled trial
    Light, M
    Dunbar, F
    Shea, S
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S275 - S275
  • [2] A double-blind, placebo-controlled study of risperidone in adults with autistic disorder and other pervasive developmental disorders
    McDougle, CJ
    Holmes, JP
    Carlson, DC
    Pelton, GH
    Cohen, DJ
    Price, LH
    [J]. ARCHIVES OF GENERAL PSYCHIATRY, 1998, 55 (07) : 633 - 641
  • [3] Memantine as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial
    Ghaleiha, Ali
    Asadabadi, Mahtab
    Mohammadi, Mohammad-Reza
    Shahei, Maryam
    Tabrizi, Mina
    Hajiaghaee, Reza
    Hassanzadeh, Elmira
    Akhondzadeh, Shahin
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2013, 16 (04): : 783 - 789
  • [4] Minocycline as Adjunctive Treatment to Risperidone in Children with Autistic Disorder: A Randomized, Double-Blind Placebo-Controlled Trial
    Ghaleiha, Ali
    Alikhani, Rosa
    Kazemi, Mohammad-Reza
    Mohammadi, Mohammad-Reza
    Mohammadinejad, Payam
    Zeinoddini, Atefeh
    Hamedi, Mehdi
    Shahriari, Mona
    Keshavarzi, Zahra
    Akhondzadeh, Shahin
    [J]. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2016, 26 (09) : 784 - +
  • [5] Celecoxib as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial
    Mahtab Asadabadi
    Mohammad-Reza Mohammadi
    Ahmad Ghanizadeh
    Amirhossein Modabbernia
    Mandana Ashrafi
    Elmira Hassanzadeh
    Saeedeh Forghani
    Shahin Akhondzadeh
    [J]. Psychopharmacology, 2013, 225 : 51 - 59
  • [6] Celecoxib as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial
    Asadabadi, Mahtab
    Mohammadi, Mohammad-Reza
    Ghanizadeh, Ahmad
    Modabbernia, Amirhossein
    Ashrafi, Mandana
    Hassanzadeh, Elmira
    Forghani, Saeedeh
    Akhondzadeh, Shahin
    [J]. PSYCHOPHARMACOLOGY, 2013, 225 (01) : 51 - 59
  • [7] A double-blind, placebo-controlled trial of risperidone in children with autistic disorder
    [J]. PEDIATRIC RESEARCH, 2002, 51 (04) : 458A - 458A
  • [8] A randomized, double-blind, placebo-controlled, crossover trial of methylphenidate in children with hyperactivity associated with pervasive developmental disorders
    Posey, DJ
    McDougle, CJ
    Aman, MG
    Arnold, LE
    Scahill, L
    McCracken, JT
    Tierney, E
    Vitiello, B
    Chuang, S
    [J]. NEUROPSYCHOPHARMACOLOGY, 2004, 29 : S142 - S143
  • [9] A double-blind placebo-controlled trial of risperidone in autistic disorder
    McDougle, C
    Aman, MG
    McCracken, JT
    Scahill, L
    Tierney, E
    Vitiello, B
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 : S327 - S328
  • [10] Riluzole as an Adjunctive Therapy to Risperidone for the Treatment of Irritability in Children with Autistic Disorder: A Double-Blind, Placebo-Controlled, Randomized Trial
    Ali Ghaleiha
    Effat Mohammadi
    Mohammad-Reza Mohammadi
    Mehdi Farokhnia
    Amirhossein Modabbernia
    Habibeh Yekehtaz
    Mandana Ashrafi
    Elmira Hassanzadeh
    Shahin Akhondzadeh
    [J]. Pediatric Drugs, 2013, 15 : 505 - 514
12345